Peripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR): Diagnostic and Therapeutic Challenges

Peripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR): Diagnostic and Therapeutic Challenges

<i>Background and Objectives:</i> Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is a peripheral retinal vascular abnormality that is likely underreported. We review the differential diagnoses, etiology, and treatment options for PEHCR. <i>Methods:</i> We present...

Full description

Bibliographic Details
Main Authors:	Kevin F. Elwood, Paige J. Richards, Kathleen R. Schildroth, Mihai Mititelu
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Medicina
Subjects:	choroidal neovascular membrane pseudomelanoma PEHCR retinal vascular peripheral lesion anti-vascular endothelial growth factor (anti-VEGF)
Online Access:	https://www.mdpi.com/1648-9144/59/9/1507

Similar Items

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
by: Abraham Hang, et al.
Published: (2023-08-01)

Presumed Melanocytoma-Associated Choroidal Neovascular Membrane with Hemorrhage Successfully Treated with Intravitreal Aflibercept Injections
by: Austin S. Yu, et al.
Published: (2023-09-01)

Choroidal Neovascular Membranes in Retinal and Choroidal Tumors: Origins, Mechanisms, and Effects
by: Federico Di Staso, et al.
Published: (2023-01-01)

Pseudomelanoma at a Referral Center in Iran
by: Fariba Ghassemi, et al.
Published: (2014-01-01)

Results of Intravitreal Anti-VEGF Injection in Choroidal Neovascularization Caused by Pathologies Other Than Age-Related Macular Degeneration
by: Mehmet Ozveren
Published: (2020-08-01)

Long-term efficacy and safety of anti-VEGF therapy in retinitis pigmentosa: a case report
by: Manabu Miyata, et al.
Published: (2018-09-01)

Spotlight on Faricimab in the Treatment of Wet Age-Related Macular Degeneration: Design, Development and Place in Therapy
by: Nair AA, et al.
Published: (2022-09-01)

Multimodal Imaging in the Management of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy
by: Ahmed M. Hagag, et al.
Published: (2020-06-01)

Personalized Approach in Treatment of Neovascular Age-Related Macular Degeneration
by: Radina Kirkova, et al.
Published: (2022-09-01)

The Role of Optical Coherence Tomography Angiography (OCTA) in Detecting Choroidal Neovascularization in Different Stages of Best Macular Dystrophy: A Case Series
by: Yaqoob Qaseem, et al.
Published: (2021-02-01)

Recurrence of Macular Hole Retinal Detachment after Intravitreal Ranibizumab Injection for the Treatment of Choroidal Neovascularization from the Remaining Macular Hole Edge
by: Keiko Otsuka, et al.
Published: (2012-12-01)

Influencing factors of poor response to anti-vascular endothelial growth factor drug therapy for wet age-related macular degeneration and therapeutic strategy of targeting pericytes
by: Han-Ran Zheng, et al.
Published: (2023-12-01)

Long-term peripheral retinal vascular behavior in retinopathy of prematurity patients treated with ranibizumab intravitreal injection as monotherapy using fluorescein angiography
by: Raghad Al Rasheed, et al.
Published: (2022-08-01)

The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion
by: Sheng Qu, et al.
Published: (2024-01-01)

Choroidal neovascularization activity and structure by optical coherence tomography angiography in age related macular degeneration
by: M. A. Kovalevskaya, et al.
Published: (2021-12-01)

Treatment of neovascular glaucoma by anti-vascular endothelial growth factor combined with ultrasonic ciliary plasty
by: Yu-Hao Wang, et al.
Published: (2023-04-01)

Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review
by: Arthur Baston, et al.
Published: (2021-05-01)

A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment
by: Danielė Urbonavičiūtė, et al.
Published: (2022-12-01)

Serpiginous Choroiditis Complicated with Choroidal Neovascular Membrane Detected using Optical Coherence Tomography Angiography: A Case Series and Literature Review
by: Asli Perente, et al.
Published: (2021-10-01)

Application and mechanism of anti-VEGF drugs in age-related macular degeneration
by: Dawei Song, et al.
Published: (2022-09-01)

Management of Submacular Hemorrhage Using Intravitreal Brolucizumab with Pneumatic Displacement: A Case Series
by: Somnath Chakraborty, et al.
Published: (2022-11-01)

Epigallocatechin-3-Gallate, an Active Green Tea Component to Support Anti-VEGFA Therapy in Wet Age-Related Macular Degeneration
by: Janusz Blasiak, et al.
Published: (2023-07-01)

Peripheral Exudative Hemorrhagic Chorioretinopathy: A Variant of Polypoidal Choroidal Vasculopathy?
by: Arman Mashayekhi, et al.
Published: (2013-01-01)

Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes
by: Meng-Tian Kang, et al.
Published: (2024-03-01)

Current advance in the application of anti-vascular endothelial growth factor drugs in wet age-related macular degeneration
by: Ling-Yi Ouyang, et al.
Published: (2020-01-01)

Comparative study on the efficacy of different dosage regimens of Ranibizumab in the treatment of choroid neovascularization secondary to pathological myopia
by: Meng-Ying Peng, et al.
Published: (2022-11-01)

Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling
by: Yimeng Sun, et al.
Published: (2021-11-01)

Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches
by: Federico Ricci, et al.
Published: (2020-11-01)

The recurrent nevus phenomenon: case series
by: Beata Zagórska, et al.
Published: (2022-10-01)

Second eyes to develop neovascular age-related macular degeneration have fewer symptoms and better one-year visual outcomes
by: F. Sema Akkan Aydoğmuş, et al.
Published: (2023-07-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
by: Yingbin Fu, et al.
Published: (2024-02-01)

The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
by: Henrik Faatz, et al.
Published: (2022-11-01)

Comparison of morphometric changes in the chorioretinal complex after anti-VEGF treatment in patients with pathologic myopia versus those with neovascular age-related macular degeneration
by: O.M. Blavatska, et al.
Published: (2018-02-01)

Optical coherence tomography angiography as an indicator of the efficacy of treatment for choroidal neovascularization
by: F. A. Bakhritdinova, et al.
Published: (2022-04-01)

Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01)

Retinopathy of Prematurity
by: Kadir Kırboğa, et al.
Published: (2014-12-01)

Analysis of intravitreal using of anti vegf-medications for diseases of fundus accompanied by exudation and neovascularization
by: N. G. Zavgorodnya, et al.
Published: (2013-08-01)

Factors Influencing Visual Acuity in Patients with Active Subfoveal Circumscribed Polypoidal Choroidal Vasculopathy and Changes in Imaging Parameters
by: Fan Xia, et al.
Published: (2023-09-01)

Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series
by: Ahmad Mirshahi, et al.
Published: (2021-01-01)

Prediction of Visual Acuity in Pathologic Myopia with Myopic Choroidal Neovascularization Treated with Anti-Vascular Endothelial Growth Factor Using a Deep Neural Network Based on Optical Coherence Tomography Images
by: Migyeong Yang, et al.
Published: (2023-08-01)